miRoncol

📍 Kanata, Canada🗓 Founded 2021👥 5 employees💰 Last funded Sep 2021
Medical and Diagnostic Laboratories🌐 mironcol.com
Website LinkedIn
miRoncol is developing an innovative technology to screen 12+ solid tumor cancers in one blood test. Based on microRNA (miRNA), it is highly accurate, highly affordable, and highly accessible using widely available PCR equipment. Enabled by breakthrough technology, miRoncol aims to democratize access to early cancer detection and save lives from cancer.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in miRoncol?
miRoncol has 1 investors on record on gritt.io, including 1 early-stage backers.
When did miRoncol last raise funding?
The most recent investment in miRoncol recorded on gritt.io was in September 2021.
When was miRoncol founded?
miRoncol was founded in 2021.
What industry is miRoncol in?
miRoncol operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is miRoncol based?
miRoncol is headquartered in Kanata, Canada.